Approval is for use in myelofibrosis patients with moderate to severe anaemia who are JAK-naive or previously treated with ...

NEW YORK, NY / ACCESS Newswire / March 22, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...

Harvey Jones has spotted signs of life in the GSK share price. Which is a relief after its recent troubles, so can the FTSE ...

After a year of controversy and complaints, Sen. Elizabeth Warren is asking a federal watchdog to investigate GSK over its ...

GSK GSK stock has risen 16.9% year to date compared with an increase of 7.0% for the industry. The stock has also ...

Shares of GSK PLC GSK slipped 1.73% to £15.05 Wednesday, on what proved to be an all-around positive trading session for the ...

GSK PLC closed 15.77% below its 52-week high of £18.24, which the company reached on May 16th.

GSK plc (LON:GSK – Get Free Report)’s share price passed above its two hundred day moving average during trading on Thursday ...

NEW YORK CITY, NY / ACCESS Newswire / March 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...

In its effort to rival GSK’s shingles vaccine Shingrix, Curevo Vaccine has circled up $110 million and recruited two former ...

GSK’s ViiV Healthcare has shared clinical data on three potential long-acting HIV treatments, providing a look at how its ...

Gilead stock fell Wednesday afternoon, as did shares in GSK (GSK), the majority owner of ViiV. Gilead Sciences has been one of the best-performing large biotech companies over the past year ...